Latest round

Series B

Last raised

Oct 2019

Total raised

$36M

Investors

7

About PierianDx

PierianDx, Inc.Founded in 2014 in the US, PierianDx, Inc. provides genomic analysis services and underwent a significant operational shift with its acquisition by Summa Equity in 2022. The original founders, Rajeev Nandan and Rakesh Nagarajan, have a history in developing innovative health tech solutions.Operating under the Velsera brand, PierianDx offers a comprehensive Clinical Genomics Workspace that facilitates the analysis of genomic findings and the creation of actionable reports.PierianDx generates revenue primarily through subscription-based models for its Clinical Genomics Workspace and associated professional services, which include assay selection and clinical interpretation support.Following the acquisition by Summa Equity in 2022, PierianDx is focused on expanding its offerings and geographic reach. The company plans to launch new products designed to enhance genomic testing capabilities within the next year. Targeted expansion into new markets includes increasing presence in Asia and South America by 2024.

Who invested in PierianDx

7 investors across 2 rounds

See all investors in PierianDx

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Oct 28, 2019

    Amount

    $27M

    Investors

    Locked

  2. Series A

    Jan 7, 2016

    Amount

    $9.3M

    Investors

    Locked

Questions about PierianDx

Who invested in PierianDx?

PierianDx has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has PierianDx raised?

PierianDx has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did PierianDx last raise money?

PierianDx's most recent round on record is a Series B, in Oct 2019.

What does PierianDx do?

PierianDx is a software company.

Where is PierianDx headquartered?

PierianDx is headquartered in US.

Which VCs invest in companies like PierianDx?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at PierianDx's stage. Their profiles are linked below.

Raising like PierianDx? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.